Skip to main content

Advertisement

Log in

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Weber T (2008) Progressive multifocal leukoencephalopathy. Neurol Clin 26:833–854. doi:10.1016/j.ncl.2008.03.007

    Article  PubMed  Google Scholar 

  2. Weber T, Klapper PE, Cleator GM, Bodemer M, Lüke W, Knowles W, Cinque P, Van Loon AM, Grandien M, Hammarin AL, Ciardi M, Bogdanovic G (1997) Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis. J Virol Methods 69:231–237

    Article  CAS  PubMed  Google Scholar 

  3. Cinque P, Koralnik I, Clifford D (2003) The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalophaty: defining a consensus terminology. J Neurovirol 9(Suppl 1):88–92. doi:10.1080/713831421

    Article  CAS  PubMed  Google Scholar 

  4. Pelosini M, Focosi D, Rita F, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M (2008) Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 87:405–412. doi:10.1007/s00277-007-0411-6

    Article  PubMed  Google Scholar 

  5. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834–4840. doi:10.1182/blood-2008-10-186999

    Article  CAS  PubMed  Google Scholar 

  6. Tuccori M, Focosi D, Blandizzi C, Del Tacca M, Petrini M (2009) Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis. J Natl Cancer Inst 110:1288–1289. doi:10.1093/jnci/djp256

    Google Scholar 

  7. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380–1383. doi:10.1126/science.1103492

    Article  CAS  PubMed  Google Scholar 

  8. Cettomai D, McArthur JC (2009) Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 66:255–258

    Article  PubMed  Google Scholar 

  9. Chapagain ML, Sumibcay L, Gurjav U, Kaufusi PH, Kast RE, Nerurkar VR (2008) Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirol 14:448–454. doi:10.1080/13550280802235916

    Article  CAS  PubMed  Google Scholar 

  10. Chapagain ML, Verma S, Mercier F, Yanagihara R, Nerurkar VR (2007) Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364:55–63. doi:10.1016/j.virol.2007.02.018

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Tuccori.

Additional information

Marco Tuccori and Daniele Focosi contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuccori, M., Focosi, D., Maggi, F. et al. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab. Ann Hematol 89, 519–522 (2010). https://doi.org/10.1007/s00277-009-0819-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0819-2

Keywords

Navigation